Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0126 | 1 | 1 |
Trypanosoma brucei | serine peptidase, clan SC, family S9A-like protein | 0.005 | 0.3271 | 0.3271 |
Loa Loa (eye worm) | nicotinic acetylcholine receptor alpha subunit | 0.0087 | 0.6542 | 0.6542 |
Echinococcus granulosus | nicotinic acetylcholine receptor a11 subunit | 0.0087 | 0.6542 | 0.6542 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0013 | 0 | 0.5 |
Brugia malayi | nicotinic acetylcholine receptor alpha subunit, putative | 0.0087 | 0.6542 | 0.6542 |
Trypanosoma brucei | prolyl oligopeptidase, putative | 0.005 | 0.3271 | 0.3271 |
Echinococcus multilocularis | nicotinic acetylcholine receptor alpha subunit | 0.0087 | 0.6542 | 0.6542 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0013 | 0 | 0.5 |
Trypanosoma brucei | prolyl endopeptidase | 0.0126 | 1 | 1 |
Trypanosoma cruzi | prolyl endopeptidase | 0.0126 | 1 | 1 |
Trypanosoma cruzi | oligopeptidase b | 0.005 | 0.3271 | 0.3271 |
Trypanosoma brucei | oligopeptidase b | 0.005 | 0.3271 | 0.3271 |
Trypanosoma cruzi | oligopeptidase B-like protein, putative | 0.005 | 0.3271 | 0.3271 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0013 | 0 | 0.5 |
Trypanosoma cruzi | serine peptidase, clan SC, family S9A-like protein, putative | 0.005 | 0.3271 | 0.3271 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.6542 | 0.6542 |
Echinococcus multilocularis | nicotinic acetylcholine receptor a11 subunit | 0.0087 | 0.6542 | 0.6542 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.005 | 0.3271 | 0.5 |
Echinococcus granulosus | nicotinic acetylcholine receptor alpha subunit | 0.0087 | 0.6542 | 0.6542 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0013 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0013 | 0 | 0.5 |
Onchocerca volvulus | Prolyl endopeptidase homolog | 0.0126 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0013 | 0 | 0.5 |
Leishmania major | oligopeptidase b | 0.005 | 0.3271 | 0.3271 |
Loa Loa (eye worm) | hypothetical protein | 0.0126 | 1 | 1 |
Echinococcus granulosus | nicotinic acetylcholine receptor subunit alpha 8 | 0.0087 | 0.6542 | 0.6542 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0013 | 0 | 0.5 |
Echinococcus granulosus | prolyl endopeptidase | 0.0126 | 1 | 1 |
Echinococcus multilocularis | nicotinic acetylcholine receptor subunit alpha 8 | 0.0087 | 0.6542 | 0.6542 |
Toxoplasma gondii | prolyl endopeptidase | 0.0126 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S9, acylaminoacyl-peptidase-like serine peptidase | 0.0013 | 0 | 0.5 |
Mycobacterium ulcerans | protease II (oligopeptidase B), PtrB | 0.005 | 0.3271 | 0.5 |
Leishmania major | oligopeptidase B-like protein,serine peptidase, clan SC, family S9A-like protein | 0.005 | 0.3271 | 0.3271 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0013 | 0 | 0.5 |
Trypanosoma cruzi | oligopeptidase b | 0.005 | 0.3271 | 0.3271 |
Leishmania major | prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative | 0.0126 | 1 | 1 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0013 | 0 | 0.5 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Onchocerca volvulus | Putative nachr subunit | 0.0087 | 0.6542 | 0.6542 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0126 | 1 | 1 |
Plasmodium falciparum | peptidase, putative | 0.0013 | 0 | 0.5 |
Echinococcus multilocularis | prolyl endopeptidase | 0.0126 | 1 | 1 |
Mycobacterium tuberculosis | Probable protease II PtrBa [first part] (oligopeptidase B) | 0.0113 | 0.8828 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.